An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors

PURPOSE: The immune checkpoint inhibitors (ICIs) have resulted in subgroups of patients with metastatic melanoma achieving high-quality durable responses. Metastatic melanoma survivors are a new population in the era of cancer survivorship. The aim of this study was to evaluate metastatic melanoma s...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Reilly, Aine, Hughes, Peta, Mann, Jasmine, Lai, Zhuangming, Teh, Jhia Jiat, Mclean, Emma, Edmonds, Kim, Lingard, Karla, Chauhan, Dharmisha, Lynch, Joanna, Au, Lewis, Ludlow, Aileen, Pattison, Natalie, Wiseman, Theresa, Turajlic, Samra, Gore, Martin, Larkin, James, Husson, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954131/
https://www.ncbi.nlm.nih.gov/pubmed/31089820
http://dx.doi.org/10.1007/s00520-019-04818-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954131/
https://www.ncbi.nlm.nih.gov/pubmed/31089820
http://dx.doi.org/10.1007/s00520-019-04818-w

Ejemplares similares